Your browser doesn't support javascript.
loading
Ablation Strategies for Persistent Atrial Fibrillation: Beyond the Pulmonary Veins.
Baqal, Omar; Shafqat, Areez; Kulthamrongsri, Narathorn; Sanghavi, Neysa; Iyengar, Shruti K; Vemulapalli, Hema S; El Masry, Hicham Z.
Affiliation
  • Baqal O; Department of Cardiovascular Medicine, Mayo Clinic, Phoenix, AZ 85054, USA.
  • Shafqat A; College of Medicine, Alfaisal University, Riyadh 11533, Saudi Arabia.
  • Kulthamrongsri N; Department of Cardiovascular Medicine, Mayo Clinic, Phoenix, AZ 85054, USA.
  • Sanghavi N; St. George's University School of Medicine, West Indies P.O. Box 7, Grenada.
  • Iyengar SK; Department of Cardiovascular Medicine, Mayo Clinic, Phoenix, AZ 85054, USA.
  • Vemulapalli HS; Department of Cardiovascular Medicine, Mayo Clinic, Phoenix, AZ 85054, USA.
  • El Masry HZ; Department of Cardiovascular Medicine, Mayo Clinic, Phoenix, AZ 85054, USA.
J Clin Med ; 13(17)2024 Aug 25.
Article in En | MEDLINE | ID: mdl-39274244
ABSTRACT
Despite advances in ablative therapies, outcomes remain less favorable for persistent atrial fibrillation often due to presence of non-pulmonary vein triggers and abnormal atrial substrates. This review highlights advances in ablation technologies and notable scientific literature on clinical outcomes associated with pursuing adjunctive ablation targets and substrate modification during persistent atrial fibrillation ablation, while also highlighting notable future directions.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: J Clin Med Year: 2024 Document type: Article Affiliation country: United States Country of publication: Switzerland

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: J Clin Med Year: 2024 Document type: Article Affiliation country: United States Country of publication: Switzerland